A randomized clinical trial of the effect of uric acid-lowering therapy on blood lipid levels in gout patients

Study on the effect of uric acid-lowering therapy on blood lipid levels in gout patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100049652

Enrollment

Unknown

Registered

2021-08-07

Start date

2021-08-05

Completion date

Unknown

Last updated

2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gout

Interventions

2:urate-lowering therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who meet the diagnostic criteria for gout.

Exclusion criteria

Exclusion criteria: With abnormal liver function, tumors, and pregnant patients.

Design outcomes

Primary

Measure	Time frame
lipid;	—

Secondary

Measure	Time frame
serum uric acid;	—

Countries

China

Contacts

Public ContactLi Changgui

the Affiliated Hospital of Qingdao University

swy8710@163.com+86 532 82912015

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026